LLY Jan 2025 1120.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:02AM EDT. Market open.
| Previous close | 7.30 |
| Open | 8.00 |
| Bid | 7.65 |
| Ask | 8.30 |
| Strike | 1,120.00 |
| Expiry date | 2025-01-17 |
| Day's range | 8.00 - 8.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 131 |
ZacksEli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
Eli Lilly's (LLY) two phase III studies on its once-weekly insulin, efsitora alfa, meet their primary endpoint of non-inferior reduction in blood sugar levels compared with daily basal insulins.
ZacksPharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Bayer (BAYRY) releases Q1 results. J&J (JNJ) set to acquire private biotech, Proteologix, which will add atopic dermatitis candidates.
Zacks4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
Though obesity drugs continue to gain traction, it is currently a duopoly market. As analysts expect demand to grow at an encouraging pace, several biotech/pharma companies are rushing to enter this space.
© 2024 Yahoo. All rights reserved.